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ABSTRACT
In this paper, we investigated the anti-microbial, anti-oxidant, phytotoxic and immunomodulatory activity of plant
Bauhinia variegata and also established the presence of important phytoconstituents which might signify its anti-
cancer property. Phytochemical screening, anti-microbial assay, phytotoxicity assay, anti-oxidant assay and im-
munomodulatory analysis was done according to the protocol established at Department of Biotechnology, Kath -
mandu University and Panjwani Center for Molecular Medicine and Drug Research, University of Karachi, Pak-
istan. In the phytochemical screening, we observed the presence of different phytochemicals like steroids, ter -
penoids, flavonoids, reducing sugars and glycosides. In case of antimicrobial assay, the plant was found to be most
effective against Bacillus cereus with the highest zone of inhibition (ZOI) of 12 mm and against Rhizopus with
ZOI of 11 mm. During the antioxidant assay in comparison to ascorbic acid; at highest concentration, the scav-
enging activity shown by the plant  B. variegata are 43.38% as compared to ascorbic acid 89.25%. In the im-
munomodulatory assay at the highest concentration i.e. 250 µg/mL, the plant showed 75.1% effect, which showed
that the plant has potential anti-inflammatory potential. In phytotoxicity assay, B. variegata showed 20% phyto-
toxicity. B. variegata has thus been proven to be an important candidate to be used as an antimicrobial, antioxi-
dant, anti-inflammatory, phytotoxic and anticancer agent. Separation of pure compounds with bioassay guided ex-
traction, spectrometric analysis and subsequent cytotoxicity assay of the pure bioactive compounds from B. varie-
gate is highly recommended as crude extract itself showed promising phytotoxicity and other pharmaceutical po-
tential.  
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Plants have been the single most productive source
of leads for the development of drugs, and over a hun-
dred new products are already in clinical development.
Indeed, several scientific studies have described the use
of various medicinal plants and their constituents for
treatment of diseases. Plants have shown the presence
of many valuable compounds, such as lignans, flavon-
oids, tannins, polyphenols, triterpenes, sterols, and al-
kaloids, that show a wide spectrum of pharmacological
activities,  including  anti-inflammatory,  anti-amyloido-
genic, anti-cholinesterase, hypolipidemic, and antioxid-
ant  effects  [1].  Considerable  research  on  pharma-
cognosy,  phytochemistry,  pharmacology  and  clinical
therapeutics has been carried out on ayurvedic medi-
cinal plants. Natural products, including plants, anim-
als and minerals have been the basis of treatment of
human diseases [2]. Many complementary and altern-
atives  medicines  are  offered  to  patients  with  cancer.
Among  them,  herbal  medicines  have  a  substantial
place. These plants are mainly used to reduce adverse
effects of anticancer treatments and for specific antic-
ancer properties [3]. Plant extracts are kinds of import-
ant anticancer drugs. Anticancer drugs research has fo-
cused on several important plant extracts such as res-
veratrol,  ricin,  epigallocatechin-3-gallate, oridonin,  ju-
glone, quercetin, matrine, nordihydroguaiaretic acid.
In vitro and in vivo studies have shown that the an-
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titumor mechanism of plant extract includes induction
of  apoptosis,  cytotoxicity,  redifferentiation,  anti-an-
giogenesis, anti-invasion and anti-metastasis. Plant ex-
tracts have characteristics of multi-link and multi-tar-
get. Part of plant extracts have been used in preclinical
studies. In-depth study of the anti-tumor mechanisms
of plant extracts on cancer treatment is important, and
the full  mechanism needs  further  study [4].  A huge
reservoir of bioactive compounds exists in many spe-
cies  of  plants  of  Earth,  only  a  small  percentage  of
which have been examined and continued to be an im-
portant source of anticancer agents. Worldwide efforts
are  ongoing  to  identify  new  anticancer  compounds
from plants. With the current decline in the number of
new  molecular  entities  from  the  pharmaceutical  in-
dustry, novel anticancer agents are being sought from
traditional medicines [5]. A number of undesired side
effects sometimes occur during chemotherapy. Natural
therapies, such as the use of plant-derived products in
cancer treatment, may reduce adverse side effects. Cur-
rently, few plant products are being used to treat can-
cer. However, a myriad of many plant products exist
that have shown very promising anti-cancer properties
in vitro, but have yet to be evaluated in humans [6].
For over 40 years, natural products have served us well
in combating cancer. The main sources of these suc-
cessful compounds are plants from the terrestrial and
marine  environments.  Another  major  contribution
comes from plant alkaloids. A vast array of metabolites
can be obtained from the marine world, which can be
used  for  effective  cancer  treatment.  The  search  for
novel drugs is still a priority goal for cancer therapy,
due to the rapid development of resistance to chemo-
therapeutic drugs. In addition, the high toxicity usually
associated with some cancer chemotherapy drugs and
their undesirable side-effects increase the demand for
novel anti-tumour drugs active against untreatable tu-
mours,  with  fewer  side-effects  and/or  with  greater
therapeutic efficiency [7]. Studies on a wide spectrum
of  plant  secondary  metabolites  extractable  as  natural
products from fruits, vegetables, teas, spices, and tradi-
tional medicinal herbs, show that these plant natural
products can act as potent anti-inflammatory, antioxid-
ant or anticancer agents. The recent advances in gen-
omics, proteomics and metabolomics have enabled bio-
logists to better investigate the potential use of immun-
omodulatory natural products for treatment or control
of various cancerous diseases. The cancer preventive or
protective activities of the various immunomodulatory
natural products lie in their effects on cellular levels in-
cluding detoxifying  and antioxidant  enzyme systems,
and the induction of anti-inflammatory and antitumor
or anti-metastasis responses, often by targeting specific
key transcription factors  like  nuclear  factor kappa B
(NF-kB),  activator  protein  (AP-1),  signal  transducers
and activators of transcription (STAT) and other pro-
teins [8]. Natural products have been the biggest single
source of anticancer drugs and there are continued ef-
forts  to  explore  the  bioactive  chemicals.  Diversity
provided  by  nature  in  order  to  find new lead  com-
pounds,  bioassay  test  methods  have  developed  into
high throughput screening assays using both cell-based
and molecular approaches [9].
This  few inventions related  to a  novel  anticancer
poly-herbal  composition  comprises  of  stem  bark  of
Bauhinia variegata, Oroxylum indicum, Tecomella un-
dulata and  leaves  of  Indigofera  tinctoria. Few novel
composition found in plants are useful in the condition
of cancer, immunosuppression, uncontrolled prolifera-
tion and angiogenesis [10, 11, 12]. Highest antioxidant
potential was found in stem bark extracts of  B. varie-
gata [13, 14, 15]. Studies showed significant antioxid-
ant activities of these B. variegata and suggested that it
showed  pronounced cytotoxic  effect  against  DU-145,
HOP-62, IGR-OV-1, MCF-7, and THP-1 human can-
cer cell lines with 90-99% cell growth inhibitory activ-
ity.  Ethyl-acetate fraction of  the plant  also produced
considerable cytotoxicity against MCF-7 and THP-1cell
lines [16, 17, 18, 19, 20, 21, 22]. Studies of ethanolic
extracts of plant material showed the presence of car-
bohydrate, protein, glycosides, triterpenoids, saponins
and steroids [23, 24]. Extracts of B.variegata have anti-
tumor, antimicrobial, antigoitrogenic, hepatoprotective
and hemagglutination properties [25]. Few studies have
revealed the chemopreventive role of  variegata flower
extracts  against  7,  12-Dimethylbena[a]  anthracene
(DMBA) induced skin carcinogenesis in mice [26]. In a
search for novel anticancer compounds From medicinal
plants, the isolated flavanone from Bauhinia was tested
for  cytotoxic  activity  against  57  human tumor lines,
representing leukemia, non-small cell lung, colon, cent-
ral nervous system, melanoma, ovarian, renal, prostate
and  breast  cancers  and  were  found  effective  against
most of them [27]. The inhibitory effect of bauhinione
on K562 cells was correlated with its inhibition and ap-
optosis  induction  in  G2-M  phase  [28].  A  novel
flavonolglycoside 5,7,3’,4’-tetrahydroxy-3-methoxy-7-O-
a-L-rhamnopyranosyl(1®3)-O-b-D-galactopyranoside-
from the roots of B. variegata showed anti-inflammat-
ory activity [29]. Similar research has been reported for
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Withania somnifera [30, 31].
Collection of plant materials
B. variegata whole plants were collected from Pa-
nauti  area of Kavre district,  Nepal.  The whole plant
were then dried  in  shade,  left  over for  15 days  and
macerated  and  powdered  with  the  help  of  kitchen
grinder. 
Preparation of plant extracts
The dry powder of B. variegata (100 g) was dipped
in 80% aq. ethanol for three days stirring twice a day
[32]. The solution at the end of third day was filtered
and then concentrated in high vacuum-rotator evapora-
tor  and  finally  all  the  solvent  was  evaporated  using
freeze  dryer  to  get  the  semi-solid  plant  extract.  The
same  procedure  was  repeated  three  times  and  the
freeze-dried extract was collected together. The yield of
the plant powder  B. variegata in aq. ethanol weighed
after  the freeze drying was 12.07 g.  The extract  was
then kept in glass vial with airtight caps and stored at
4°C. 
Phytochemical screening
Phytochemical screening was done using the meth-
ods as described [32].
1. Test  for  Alkaloids:  5  mL  of  extract  was  concen-
trated to yield a residue. Residue was dissolved in
3mL of 2% (v/v) HCl, few drops of Mayer’s reagent
was added. Appearance of the dull white precipitate
indicated the presence of basic alkaloids. 
2. Test  for  Coumarin:  4  mL  extract  solution  was
taken; 1-2 drops of water (hot) was added. Volume
was  made  half  (UV  fluorescence).  10% NH4OH
was added to another half volume (strong fluores-
cence). Presence of green fluorescence indicated the
presence of Coumarin.
3. Test for Saponins: 2 mL extract was shaken vigor-
ously for 30 seconds in a test tube. Persistence of
thick forth even after 30 minutes indicated the pres-
ence of saponins.
4. Test for Glycosides: 2 mL of extract was dried till 1
mL.  As much as  1-2mL NH4OH was added and
shaken. Appearance of cherish red colour indicated
the presence of glycosides.
5. Test  for  Reducing  Sugars:  0.5  mL of  extract  was
taken and 1ml distilled water was added. About 5-8
drops of Fehling’s solution (hot) was added. Pres-
ence of brick red precipitation indicated the pres-
ence of reducing sugar.
6. Test for steroids: 1 mL extract was dissolved in 10
mL chloroform. Equal volume of conc. H2SO4 was
added by the side of test tube. Upper layer turned
red  and  sulphuric  acid  layer  turned  yellow  with
green fluorescence. This indicated the presence of
steroids.
7. Test for Quinone: 1 mL of extract was taken. As
much as 1 mL of conc. H2SO4 was added. Forma-
tion  of  red  colour  indicated  the  presence  of
quinone.
8. Test for Terpenoids: 5 mL of extract was taken and
mixed with 2 mL of chloroform. As much as 3 mL
of conc. H2SO4 was added to form a layer. Reddish
brown precipitate formation at the interface formed
indicated the presence of terpenoids.
2, 2-diphenyl-1-picrylhydrazyl radical (DPPH) free radi-
cal scavenging assay
2, 2-diphenyl-1-picrylhydrazyl radical (DPPH) is a
dark-coloured  crystalline  powder  composed  of  stable
free-radical molecules. DPPH has major application in
laboratory research most notably in antioxidant assays.
DPPH solution (95 µL, 300 µM) in Ethanol was mixed
with test solution (5 µL, 500 µM). The reaction was al -
lowed to progress for 30 min at 37ºC and absorbance
was monitored by microplate reader, SpectraMax340 at
517 nm.  Upon reduction,  the colour of  the solution
fades (violet to pale yellow). Percent Radical Scaveng-
ing Activity (% RSA) was determined by comparison
with a Dimethyl sulfoxide (DMSO) containing control.
The concentration that causes a decrease in the initial
DPPH concentration by 50% is defined as IC-50 value.
The IC-50 values of compounds were calculated by us-
ing the EZ-Fit Enzyme kinetics software program (Per-
rella Scientific Inc. Amherst, MA, USA). N-acetylcys-
teine and ascorbic acid are used as the reference com-
pounds [32].
Agar plate diffusion method for antimicrobial activity
Medium was dissolved and autoclaved at 121°C for
15 minutes, cooled up to 45°C and then 40-50 mL me-
dia was poured in sterile 14 cm diameter petri plate,
and then allowed to solidify and kept at room tempera-
ture.  Preparation  of  plant  extract:  Stock  solution  of
400mg/mL was prepared by weighing 200mg of plant
extract in 1.5 mL eppendorf tube and the final volume
of 0.5ml of DMSO was added by micropipette. Extract
was completely dissolved by vortexing for 5-10 min-
utes.  Test  solution  of  200  mg/mL,  100  mg/mL,  50
mg/mL, and 25 mg/mL concentrations was prepared. 
Preparation of inoculums: Each culture to be tested
JTLS | J. Trop. Life. Science 84 Volume 7 | Number 1 | January| 2017
MATERIALS AND METHODS                                         
5
Jaya Bhandari, Bhupal G Shrestha, 2017
was  streaked  onto  nutrient  agar  to  obtain  isolated
colonies.  Overnight  incubation  was  done  at  37°C.
Then isolated colonies were transferred by the help of
sterile loop onto Muller Hinton Broth. Overnight incu-
bation was done at rotary shaker at 37°C. 
Inoculation:  For  inoculation,  swabbing  was  done
with  the  help  of  cotton.  Sterilized  filter  paper  discs
were  dipped  into  the  desirable  concentration  of  the
plant extracts then applied to the plates; incubated at
37°C for 24 hours. After incubation, the diameter of
the Zone of inhibition was measured.
Phytotoxicity or Lemna bioassay for inhibitors and pro-
moters of plant growth
The members of Lemnaceae family are suitable or-
ganisms to investigate physiological processes. It  is  a
quick measure of phytotoxicity of the materials.  The
Lemna minor phytotoxicity assay is  a useful primary
screen for weedicides search. It  is  also observed that
natural  antitumor  compounds  can  inhibit  the  lemna
growth.
E-Medium is prepared by mixing its constituents in
1000 mL distilled water and pH is adjusted between 6.0
and  7.0  by  adding  KOH  pellets  (Stock  solution).
Working E-medium is prepared by mixing 100 ml of
stock solution and 900 mL of distilled water. 30 mg for
crude extract/ compound is dissolved in 1.5 mL of sol-
vent (Methanol/ Ethanol etc.) serving as stock solution.
Three flasks are inoculated with 10, 100 and 1000 µL of
solution pipette from the stock solution for 10, 100 and
1000  µg/mL.  The  solvent  was  allowed  to  evaporate
overnight. Add 20 mL of working E. medium and then
plant of Lemna minor, each containing a rosette of two
to three fronds, to each flask (total 20 fronds). Other
flasks  supplemented  with  E-medium  and  reference
(standard drug) plant growth inhibitors and promoters
serve  as  negative  and  positive  controls,  respectively.
Place the flaks in growth cabinet for seven days. Plants
should  be  examined  daily  during  incubation.  Count
and record number of fronds per flasks on day 7. Re-
sults are analyzed as growth regulation in % age, calcu-
lated with reference to the negative control by this for-
mula.
Immunomodulatory  assay  (for  anti-inflammatory  po-
tential)
Immunomodulation is the regulation and modula-
tion of immunity either by enhancing or by reducing
the immune response whereas an immunomodulator 
Table 1. Results of phytochemical screening of B. variegata
Phytochemicals B. variegata
Alkaloids Available
Tannins Available
Reducing sugar Available
Coumarin Available
Glycosides Available
Quinone Not-available
Steroids Not-available
Terpenoids Available
Saponin Available
Flavonoids Available
may be defined as a biological or synthetic substance,
which can stimulate, suppress or modulate any of the
components of the immune system including both in-
nate and adaptive arms of the immune responses.
Medicinal plants are a rich source of immunomod-
ulators.  Since the drugs available in the market have
adverse side effects, the use of natural products as an
alternative method for treatment has been on the rise
in the last few decades. A large number of plants like
Actinidia, Aesculus, Allium, Aloevera, Asparagus, Cen-
tella,  Emblica,  Magnifera,  Withania,  Piper  and
Tinosporaetc possess potent immunomodulatory activ-
ity.
Luminol-enhanced  chemiluminescence  assay  was
performed, as described by Helfand [33]. Briefly 25 µl
of diluted whole blood HBSS++ (Hanks Balanced Salt
Solution,  containing  Calcium  Chloride  and  Magne-
sium Chloride) [Sigma, St. Louis, USA] was incubated
with 25 µL of three different concentrations of com-
pounds (1, 10 and 100 µg/ml), each in triplicate. Con-
trol  wells  received  HBSS++  and  cells,  but  no  com-
pounds. Test was performed in white half area 96 well
plates  [Costar,  NY,  USA],  which  was  incubated  at
37ºC for 15 minutes in the thermostat chamber of lu-
minometer [Labsystems, Helsinki, Finland]. After incu-
bation,  25  µl  of  serum  opsonized  zymosan  (SOZ)
[Fluka, Buchs, Switzerland] and 25 µL of intracellular
reactive oxygen species (ROS) detecting probe, luminol
[Research Organics, Cleveland, OH, USA] were added
into  each  well,  except  blank  wells  (containing  only
HBSS++). The level of the ROS was recorded in lumi-
nometer in term of relative light units (RLU). Standard
used for the assay is Ibuprofen (IC-50 = 11.2 ± 1.9).
In the phytochemical screening, as shown in Table
1, we observed the presence of different phytochemic
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als  like alkaloids,  tannins,  reducing sugar,  coumarin,
glycosides, terpenoids, saponins and flavonoids. 
Antimicrobial assay was performed with the plant
extract of  B. variegata by agar plate diffusion method.
Five different antibiotics were used as standard drugs
(Figure 1).
In the phytochemical screening, as shown in Table
1, we observed the presence of different phytochemic-
als  like alkaloids,  tannins,  reducing sugar,  coumarin,
glycosides, terpenoids, saponins and flavonoids. 
Antimicrobial assay was performed with the plant
extract of  B. variegata by agar plate diffusion method.
Five different antibiotics were used as standard drugs.
Results of antimicrobial assay
In case of antimicrobial assay Figure 2, B. variegata
showed ZOI,  of  12 mm, 10 mm, 8 mm and 8 mm
against Bacillus cereus at the concentration gradient of
200 µg/mL, 100 µg/mL, 50 µg/mL and 25 µg/mL re-
spectively. Against Bacillus thuringiensis it was 10 mm,
7 mm, 7 mm and 6 mm; against Escherichia coli it was
7.5 mm, 7 mm, 7 mm and 6.5 mm; against Pseudomo-
nas aeruginosa it was 10 mm, 7 mm, 6.5 mm and 6.5
mm; against  Pseudomonas mirabilis it was 11 mm, 9
mm, 7 mm and 7 mm; against Rhizopus it was 11 mm,
10 mm, 7.5 mm and 7 mm; against Aspergillus flavus
it was 9 mm, 7 mm, 6.5 mm and 6.5 mm and against
B. subtillis it was 9 mm, 7 mm, 6.5 mm and 6.5 mm;
respectively  at  the  above  mentioned  concentration
gradient.
Results of antioxidant assay 
During the antioxidant assay Figure 3, in compar-
ison to Ascorbic acid at 1 µg/mL, 2 µg/mL, 3 µg/mL, 4
µg/mL, 5 µg/mL and 10 µg/mL, the scavenging activity
shown by the plant  B. variegata was 11.16%, 16.3%,
19.6%, 21.9%, 34.12% and 43.38% respectively and by
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Figure 3. Results of antioxidant assay of B. variegata
Figure 4. Immunomodulatory assay of B. variegata
ascorbic acid it was 8.07%, 18.45%, 25.81%, 35.46%,
44.25% and 89.25% respectively, in the same concen-
tration gradient.
Results of immunomodulatory assay
In the immunomodulatory assay Figure 4, anti-in-
flammatory  assay,  at  250  µg/mL,  50  µg/mL and  10
µg/mL  the  average  immunomodulatory  effect  are
75.1%, 23.6% and 16.4%. 
Result of phytotoxicity assay
In phytotoxicity assay, at 1000 µg/mL, 100 µg/mL
and 10 µg/mL the plant B. variegata showed 20%, 20%
and 5% phytotoxicity.
Some of the reported cytotoxicity of different plant
sample can be attributed to the synergic effect of all
secondary metabolites that could have been present in
the plants. The phytoconstituents like alkaloids, terpen-
oids  and  phenols  can  be  attributed  for  the  marked
cytotoxicity.
The prevalence of differential anti-oxidant potential
may  be  ascribed  to  their  different  phenolic  content
group  and  flavonoids  compounds.  The  extract  with
raised phenolic  content may have contributed to the
higher anti-oxidant activity.  Based on the results ob-
tained, it can be concluded that the plant contains es-
sential phyto-constituents and possess potent anti-bac-
terial,  anti-oxidant,  phytotoxic,  immunomodulatory
and anti-cancer features, as has been reported earlier
for Berberis aristata [34]. Further investigations on the
isolation of  the active  component  of  the extract  will
throw more information on the mechanism of action.
Phenolics and flavonoids from the plants are found
to possess potent antioxidants and homeostatic balance
between anti-oxidant and pro-oxidant which are repor-
ted to be significant  for physiological  functioning as
well  as  precluding  different  degenerative  debilities.
Conclusively,  results  of  our  study embodies  the  fact
that the extracts are an eminent source of natural anti-
oxidants with consequential potential in reducing the
oxidative stress  and preventing degenerative ailments
and also cancer. Bioactivity guided purification and ex-
traction of the pure compounds may lead to increased
activity of the compounds [34].
The degree of variability in antimicrobial potential
could  be  linked to the  varying  presence  of  different
phytochemicals like flavonoids and phenols having an-
tioxidant potential and play an important role in pro-
tection against oxidative stress. These phytochemicals
exhibit restriction of generation of free radicals which
damages target biomolecules. The variability in differ-
ent phytochemicals contents across populations may be
attributed  to  morphological  as  well  as  biochemical
characters of the plants. This would, however, suggest
source specific variation of antioxidant efficacies. The
phytoconstituents like alkaloids, terpenoids and phen-
ols can be attributed for cytotoxicity. The presence of
flavonoids, and saponins in isolation or in synergy in
these crude extracts used in the study might also be re-
sponsible for exhibiting anticancer efficacies. There are
testaments signifying biological interactions of flavon-
oids, polyphenols, or phenolic compounds [35].
Figure 1, 2, 3, and 4.
B.  variegata has  thus  been  proven  to  be  an
important  candidate to be used as an anti-microbial,
anti-oxidant,  anti-inflammatory,  phytotoxic  and  anti-
cancer  agent.  Separation  of  pure  compounds  with
bioassay guided extraction, spectrometric analysis and
subsequent  cytotoxicity  assay  of  the  pure  bioactive
compounds from  B. variegata is highly recommended
as crude extract itself showed promising cytotoxicity.
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